Please login to the form below
Sanofi pays $160m upfront to acquire Tidal Therapeutics
French pharma company's acquisition of pre-clinical stage biotech includes mRNA-based research platform
BioNTech forecasts €9.8bn in sales of Pfizer-partnered COVID-19 vaccine in 2021
Company also raised full year manufacturing capacity target for vaccine to 2.5 billion doses
Amgen plans acquisition of Rodeo Therapeutics
Deal could be worth over $700m including potential future milestone payments
AstraZeneca to supply US government with 500,000 additional doses of its COVID-19 antibody
AZD7442 is a long-acting antibody combination that could help to prevent and treat COVID-19
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities
Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
Five Prime's pipeline includes potentially first-in-class anti-FGFR2b antibody bemarituzumab
AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
Company can acquire asset following the completion of IND enabling studies
Merck & Co to help produce J&J’s COVID-19 vaccine in the US
Company has signed agreements to bolster vaccine manufacturing capacity
Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology asset
Development and commercialisation deal could be worth up to $1.08bn
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
AZ sells stake in Moderna for around $1.2bnAs Moderna expects COVID-19 vaccine sales to reach $18.4bn this year
-
Merck to acquire Pandion Therapeutics for $1.85bnMerck will gain a pipeline of immune modulators targeting autoimmune diseases
-
bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobinCompany announced clinical hold on gene therapy earlier this month after suspected serious adverse reaction
-
US secures a further 100 million doses of Pfizer/BioNTech’s COVID-19 vaccineUS government will pay $1.95bn for additional 100 million doses
-
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500mSandoz, the generics division of Novartis, will pay $350m upfront for three established brands
-
AZ forecasts growth in 2021 after revenues surge in Q4
Most recent quarter is first 'for many years' in which product sales were in excess of $7bn
-
EU orders another 300 million doses of Pfizer/BioNTech's COVID-19 vaccinePfizer/BioNTech's has an existing agreement with the EU for an initial 300 million doses
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Virtual congresses: video thrilled the cardio tsar
- FDA approves Roche’s Actemra COVID-19 trial
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
- When Wireless Technology Meets Drug Delivery
PMHub
integrated medhealth communication
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
